Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_1
4
100%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Phase 14 (100.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

The Effects of Epinephrine in Endotoxemia in Normal Volunteers

NCT00753402
completedphase_1

The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers

NCT01064986
completedphase_1

Inflammation and the Host Response to Injury (In Healthy Volunteers)

NCT00820989
terminatedphase_1

Genetics of Asthma - Bronchoscopy Studies

NCT00644514

Clinical Trials (4)

Showing 4 of 4 trials
NCT00753402Phase 1

The Effects of Epinephrine in Endotoxemia in Normal Volunteers

Completed
NCT01064986Phase 1

The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers

Completed
NCT00820989Phase 1

Inflammation and the Host Response to Injury (In Healthy Volunteers)

Completed
NCT00644514Phase 1

Genetics of Asthma - Bronchoscopy Studies

Terminated

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4